• Mi Re-Unir
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Buscar 
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Buscar
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Buscar

    Buscar

    Mostrar filtros avanzadosOcultar filtros avanzados

    Filtros

    Use filtros para refinar sus resultados.

    Mostrando ítems 1-7 de 7

    • Opciones de clasificación:
    • Relevancia
    • Título Asc
    • Título Desc
    • Fecha Asc
    • Fecha Desc
    • Fecha Publicación Asc
    • Fecha Publicación Desc
    • Resultados por página:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100

    Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases 

    Soriano, Vicente; Edagwa, Benson; de Mendoza, Carmen; Barreiro, Pablo; Corral, Octavio Jorge; Treviño, Ana; Gendelman, Howard E. (Future Microbiology, 2022-07)
    For two centuries, vaccines have been successful in the fight against viruses, triggering immune protection. Indeed, the elimination of smallpox, the only infectious disease eradicated to date, was made possible through ...

    Oral antivirals for the prevention and treatment of SARS-CoV-2 infection 

    Soriano, Vicente; de Mendoza, Carmen; Edagwa, Benson; Treviño, Ana; Barreiro, Pablo; Fernandez-Montero, José V.; Gendelman, Howard E. (AIDS Reviews, 2022)
    Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-threatening viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against severe COVID-19 disease manifestations ...

    Pre-Exposure Prophylaxis for viral infections other than HIV 

    Soriano, Vicente; Treviño, Ana; de Mendoza, Carmen; Moreno-Torres, Víctor; Pintos, Ilduara; Barreiro, Pablo; Corral, Octavio Jorge (Infezioni in Medicina, 2022)
    The battle against human viral infections has histori-cally relied on two medical strategies, namely vaccines to protect from contagion and antivirals to treat infected patients. In the absence of vaccines, antivirals have ...

    Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain 

    Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (Hepatology International, 2022)
    Background: Chronic viral hepatitis B, C, and D are the main causes of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented more than 2 decades ago in most EU countries. Furthermore, ...

    Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network 

    de Mendoza, Carmen; Pérez, Leire; Fernández-Ruiz, Mario; Pena, María José; Ramos, José Manuel; Richart, Alberto; Pirón, María; Rando, Ariadna; Miró, Elisenda; Reina, Gabriel; Encinas, Beatriz; Rojo, Silvia; Rodriguez-Iglesias, Antonio Manuel; Benito, Rafael; Aguilera, Antonio; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (International Journal of Infectious Diseases, 2022)
    Objectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently ...

    Is SARS-CoV-2 the only cause of long-COVID? 

    Pintos, Ilduara; Moreno-Torres, Víctor; Ibánez-Estéllez, Fatima; Corrales-Rodriguez, Pilar; Treviño, Ana; Corpas, Manuel; Corral, Octavio Jorge; Soriano, Vicente; de Mendoza, Carmen (AIDS Reviews, 2022)
    Around 10% of adults infected with SARS-CoV-2 that survive a first episode of COVID-19 appear to experience long-term clinical manifestations. The signs and symptoms of this post-acute COVID-19 syndrome (PACS) include ...

    Ultra-long-acting (XLA) antivirals for chronic viral hepatitis 

    Soriano, Vicente ; Alvarez, Carmen ; Edagwa, Benson; de Mendoza, Carmen; Montoya, Noemí ; Treviño, Ana ; Gendelman, Howard E. (Elsevier B.V., 2022)
    Viral hepatitis is among the top four causes of mortality globally, causing 1.4 million deaths each year, exceeding tuberculosis, malaria and human immunodeficiency virus. Hepatitis B and C are responsible for 90% of ...

    Mi cuenta

    AccederRegistrar

    ¿necesitas ayuda?

    Manual de UsuarioContacto: reunir@unir.net

    Listar

    todo Re-UnirComunidades y coleccionesPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de accesoEsta comunidadPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de acceso

    afina tu búsqueda

    Autor
    de Mendoza, Carmen (7)
    Soriano, Vicente (6)
    Treviño, Ana (6)
    Corral, Octavio Jorge (5)Barreiro, Pablo (4)... ver todoPalabra claveJCR (6)Scopus (6)long-acting antivirals (4)hepatitis B (3)hepatitis C (3)... ver todoFecha
    2022 (7)






    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja
     
    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja